Fernando Albericio

Jan 22, 2025 | mdpi.com | Fernando Albericio |de la Torre

1. AnalysisDuring 2024, the U.S. Food and Drug Administration (FDA) has approved 50 new drugs [1]. This figure matches the average of 50 per year for the period 2018–2023 (Figure 1), reaffirming that the COVID-19 pandemic has not significantly impacted the pharmaceutical industry. On the contrary, analysts believe that the industry’s rapid response in developing vaccines has helped boost public confidence in the pharmaceutical sector.

Jan 24, 2024 | mdpi.com | Fernando Albericio |de la Torre

1. AnalysisA year ago, we embarked on a new “normality” after the COVID-19 pandemic. Fortunately, this year (2023), we can confirm a scenario in which the disease is being treated in many countries like other diseases such as flu, which also causes a large number of deaths worldwide every year. An important outcome of the pandemic has been the establishment of mRNA technology for the development of vaccines for other diseases, such as cancer.

Jan 10, 2024 | chemistry-europe.onlinelibrary.wiley.com | James Sherwood |Fernando Albericio

Solvent properties N,N-Dimethyl formamide (DMF) is a dipolar aprotic solvent with varied uses across the polymer and fine chemical industries.

Jan 8, 2024 | preprints.org | Fernando Albericio

Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 5 January 2024 / Approved: 5 January 2024 / Online: 8 January 2024 (09:44:44 CET) De la Torre, B.G.; Albericio, F. The Pharmaceutical Industry in 2023. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Preprints 2024, 2024010523. https://doi.org/10.20944/preprints202401.0523.v1 De la Torre, B.G.; Albericio, F. The Pharmaceutical Industry in 2023.